These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32783473)

  • 21. Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes.
    Harris E
    JAMA; 2023 Apr; 329(15):1249. PubMed ID: 36988977
    [No Abstract]   [Full Text] [Related]  

  • 22. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
    Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
    Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
    [No Abstract]   [Full Text] [Related]  

  • 26. Do-It-Yourself Artificial Pancreas System Use in Pregnant Women With Type 1 Diabetes in a Real-World Setting: 2 Case Reports.
    Lemieux P; Yamamoto JM; Donovan LE
    Can J Diabetes; 2021 Dec; 45(8):804-808.e2. PubMed ID: 33648862
    [No Abstract]   [Full Text] [Related]  

  • 27. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Dual-Hormone Multicontroller for Artificial Pancreas Systems.
    Fushimi E; De Battista H; Garelli F
    IEEE J Biomed Health Inform; 2022 Sep; 26(9):4743-4750. PubMed ID: 35704538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Where Do We Stand with Closed-Loop Systems and Their Challenges?
    Jackson M; Castle JR
    Diabetes Technol Ther; 2020 Jul; 22(7):485-491. PubMed ID: 32069100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Advanced Hybrid Closed-Loop System in a Patient with Pancreas Cancer.
    Hacisahinogullari H; Caklili OT; Saribeyliler G; Rasulova N; Selcukbiricik O; Gul N; Uzum AK; Karsidag K
    Diabetes Technol Ther; 2022 Sep; 24(9):675-676. PubMed ID: 35349364
    [No Abstract]   [Full Text] [Related]  

  • 31. Current Status and Emerging Options for Automated Insulin Delivery Systems.
    Forlenza GP; Lal RA
    Diabetes Technol Ther; 2022 May; 24(5):362-371. PubMed ID: 35099302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future Perspectives.
    Tagougui S; Taleb N; Molvau J; Nguyen É; Raffray M; Rabasa-Lhoret R
    J Diabetes Sci Technol; 2019 Nov; 13(6):1077-1090. PubMed ID: 31409125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bionic pancreas: novel perspectives on insulin replacement therapies.
    Denecke C
    Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
    [No Abstract]   [Full Text] [Related]  

  • 34. An integrated multivariable artificial pancreas control system.
    Turksoy K; Quinn LT; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 diabetes: from the dream of automated insulin delivery to a fully artificial pancreas.
    Phillip M; Kowalski A; Battelino T
    Nat Med; 2024 May; 30(5):1232-1234. PubMed ID: 38448742
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.
    Kropff J; DeJong J; Del Favero S; Place J; Messori M; Coestier B; Farret A; Boscari F; Galasso S; Avogaro A; Bruttomesso D; Cobelli C; Renard E; Magni L; DeVries JH;
    Diabet Med; 2017 Feb; 34(2):262-271. PubMed ID: 27696520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the technical reliability and insulin dosing of a "do-it-yourself artificial pancreas" with a commercial hybrid closed-loop system in a "shadow-mode" scenario: An exploratory study.
    Künzler J; Züger T; Stettler C; Laimer MW; Melmer A
    Diabetes Obes Metab; 2023 Sep; 25(9):2780-2783. PubMed ID: 37311723
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 40. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
    Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.